Editas Medicine Inc

25.09.2026 г., 20:08 ч. UTC

Prime Medicine Inc shares fell sharply despite FDA clearance for its gene-editing therapy, contributing to a broader market downturn and a significant cumulative decline since Thursday.

24.09.2026 г., 20:14 ч. UTC

Editas Medicine Inc is trading higher in after-market hours, potentially influenced by Prime Medicine Inc's FDA clearance for its Investigational New Drug application.

23.09.2026 г., 22:01 ч. UTC

Editas Medicine Inc is advancing in after-market trading, reflecting a notable increase since Wednesday's close after being below its 20-day moving average.

22.09.2026 г., 19:45 ч. UTC

Editas Medicine Inc is trading higher, benefiting from strength in biotechnology stocks, despite remaining below its 20-day moving average.

21.09.2026 г., 21:51 ч. UTC

Editas Medicine Inc is trading higher in after-market hours, recovering from significant volatility, but remains 2.00% below its 20-day moving average.

18.09.2026 г., 21:51 ч. UTC

Editas Medicine Inc is advancing in after-market trading, moving higher alongside the broader market amid macroeconomic concerns and geopolitical tensions.

17.09.2026 г., 23:01 ч. UTC

Editas Medicine Inc is higher in after-market trading, recovering from earlier lows, though it remains below its 20-day moving average.

16.09.2026 г., 20:07 ч. UTC

Editas Medicine Inc is gaining in Wednesday's session, reflecting a positive trend since Tuesday's close, despite remaining below its 20-day moving average.

15.09.2026 г., 23:51 ч. UTC

Editas Medicine Inc shares are higher in after-market trading. No specific company news was identified to explain this price movement.

10.09.2026 г., 20:08 ч. UTC

Editas Medicine Inc shares are lower, extending a three-day decline amid broader biotechnology sector weakness and pressures from the European Central Bank's recent interest rate hike.

9.09.2026 г., 22:11 ч. UTC

Editas Medicine Inc shares are higher in after-market trading, reflecting a notable increase since Wednesday's close, despite being below its 20-day moving average.

8.09.2026 г., 20:08 ч. UTC

Editas Medicine appoints Dan Ory as Chief Medical Officer, shares decline sharply amid market response. The stock has reached a session low today.

4.09.2026 г., 23:02 ч. UTC

Editas Medicine Inc shares are lower during after-market hours, reflecting a decline despite being above its 20-day moving average and near one-month highs.

1.09.2026 г., 19:16 ч. UTC

Editas Medicine is participating in two investor conferences, enhancing visibility. Shares are higher today, reflecting positive investor interest in its CRISPR technology focus.

31.08.2026 г., 22:51 ч. UTC

Editas Medicine has filed a prospectus for a $400 million mixed securities shelf offering, contributing to higher shares during after-market hours.

28.08.2026 г., 20:03 ч. UTC

Editas Medicine Inc shares are lower today, retracing from earlier highs. Broader market dynamics, including rising Treasury yields, may be contributing to the decline.

27.08.2026 г., 23:02 ч. UTC

Editas Medicine Inc is trading higher in after-market hours, reflecting positive sentiment since Thursday's close and resilience despite earlier session pullbacks.

26.08.2026 г., 23:16 ч. UTC

Editas Medicine Inc shares are higher in after-market trading, positioned near the upper end of their one-month range and above the 20-day moving average.

25.08.2026 г., 19:21 ч. UTC

Editas Medicine Inc is seeing gains during Tuesday's session, reaching a peak return earlier before pulling back slightly. Broader market sentiment remains favorable for biotech stocks.

24.08.2026 г., 22:22 ч. UTC

Editas Medicine Inc shares are higher in after-market trading, showing some volatility. No specific news was identified to explain the price movement.

21.08.2026 г., 23:16 ч. UTC

Editas Medicine Inc shares are lower in after-market trading. No specific news was identified to explain the decline, though the stock remains above its 20-day moving average.

20.08.2026 г., 23:46 ч. UTC

Editas Medicine Inc is higher in after-market hours, gaining since Thursday's close. The stock is above its 20-day moving average amid no specific news.

19.08.2026 г., 23:21 ч. UTC

Editas Medicine Inc. shares are lower in after-market hours, impacted by a decline in the Biotechnology sub-sector. No specific news was identified for the movement.

17.08.2026 г., 19:16 ч. UTC

Editas Medicine Inc. shares are trading roughly flat amid overall market sentiment influenced by recent declines in U.S. retail sales and consumer sentiment.

14.08.2026 г., 22:21 ч. UTC

Editas Medicine Inc is trading lower in after-market hours, continuing a decline over the past four sessions amid broader concerns over consumer demand.

13.08.2026 г., 21:32 ч. UTC

Editas Medicine Inc advanced in after-hours trading, reflecting a shift in investor sentiment and aligning with a positive trend in the biotechnology sector.

12.08.2026 г., 19:31 ч. UTC

Editas Medicine Inc shares are lower today, continuing a decline since Tuesday. No specific news has been identified to explain the drop.

11.08.2026 г., 19:46 ч. UTC

Editas Medicine Inc shares are trading higher today, reflecting unusual strength. No specific company news was identified to explain this price action.

10.08.2026 г., 23:26 ч. UTC

Editas Medicine Inc shares are higher in after-market hours. No specific company news was identified to explain this movement amid broader market uncertainties.

7.08.2026 г., 23:16 ч. UTC

Editas Medicine Inc. shares were little changed in after-market trading, with no specific news identified. The stock remains above its 20-day moving average.